Alternatives
Alternatives to Carbidopa and Levodopa 48.75 mg/195 mg extended-release capsule
1 other presentations of Carbidopa and Levodopa 48.75 mg/195 mg extended-release capsule
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Carbidopa and Levodopa), strength (48.75 mg/195 mg) and dosage form (extended-release capsule) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Carbidopa and Levodopa 48.75 mg/195 mg extended-release capsuleThis pageOral | — | US FDA | 100 capsules, 50 pouches | Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Store in a tightly closed container, protected from light and moisture. | On request | — | Available on request |
| Rytary 48.75 mg/195 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | 100 capsules, 25 capsules | Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Store in a tightly closed container, protected from light and moisture. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Carbidopa and Levodopa 48.75 mg/195 mg extended-release capsuleNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.